company score funding investors employees industries biz model city contact
Aqemia

Drug discovery platform.

68
$32M · Series A Wendel Growth, Bpifrance, Eurazeo 51 to 100 Biotech B2B Paris, France •••••••••••@aqemia.com
BioptimusJUST ADDED

Developer of a universal AI foundation model for biology.

68
$35M · Seed Frst, Bpifrance, Sofinnova Partners 1 to 10 AI, Biotech B2B, SaaS Paris, France •••••••••••@bioptimus.com
Cure51JUST ADDED HIRING

Cancer survivors data analysis platform.

68
$16M · Seed Hitachi Ventures, Life Extension Ventures, Sofinnova Partners 11 to 50 Biotech, Data and Analytics B2B, SaaS Paris, France •••••••••••@cure51.com
MetyosJUST ADDED HIRING

Biosensors developer to combat chronic kidney disease.

64
$2M · Pre Seed Bpifrance, Kima Ventures, Cenitz 1 to 10 Health Tech, Biotech Paris, France •••••••••••@metyos.com
Adionics

Eco-friendly liquid-liquid direct lithium extraction (DLE) process developer.

64
$27M · Series B Celeste Management, Sociedad Quimica Y Minera (SQM), Bpifrance 11 to 50 Climate Tech & Green Tech, Biotech B2B Paris, France •••••••••••@adionics.com
Eligo Bioscience

Gene-editing platform.

64
$30M · Series B Sanofi Ventures, Khosla Ventures, Bpifrance 11 to 50 Health Tech, Biotech Paris, France •••••••••••@eligo.bio
SparingVision

SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal diseases.

59
$52M · Series A Ysios Capital 1 to 10 Health Tech, Biotech, Deep Tech B2B Paris, France •••••••••••@sparingvision.com
HEPHAISTOS-Pharma

Immunotherapies developer for cancer patient.

59
$2M · Seed Fournier-Majoie, Meusinvest (Noshaq), xista science ventures 1 to 10 Health Tech, Biotech Paris, France •••••••••••@hephaistos-pharma.fr
Mnemo Therapeutics

Mnemo Therapeutics specializes in biotechnology and life science.

59
$89M · Series A Sofinnova Partners 101 to 250 Health Tech, Biotech B2B Paris, France •••••••••••@mnemo-tx.com
Enterome

Cutting-edge immunomodulatory drugs for the treatment of cancer and immune diseases.

54
$3M · Series F The Leukemia & Lymphoma Society’s Therapy Acceleration Program, Omnes Capital, Nestlé Health Science 51 to 100 Health Tech, Biotech, Deep Tech, Pharma B2B Paris, France •••••••••••@enterome.com
Egle Therapeutics

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

54
$46M Bioqube Ventures 11 to 50 Health Tech, Biotech B2B Paris, France •••••••••••@egle-tx.com
Samabriva

Biomanufacturer of complex molecules.

54
$4M · Seed Meusinvest (Noshaq) 1 to 10 Biotech, Manufacturing Paris, France •••••••••••@samabriva.com
Astraveus

Automated bioprocessing system for the production of cell and gene therapies.

54
$18M · Seed AdBio Partners 11 to 50 Biotech Paris, France •••••••••••@astraveus.com
Nūmi

Breast milk producer from cell-cultured mammary glands.

54
$3M · Pre Seed Heartcore, Kima Ventures, Kost Capital 1 to 10 Biotech, FamilyTech & Parenting B2C Paris, France •••••••••••@numi.life
Gradient Denervation Technologies

Medical devices for a transvascular treatment of pulmonary hypertension.

54
$14M · Series A Sofinnova Partners, Asabys Partners 1 to 10 Health Tech, Biotech Paris, France •••••••••••@gradientdenervation.com
Eyevensys

Eyevensys creates ophthalmic therapeutic bio factories to sustainably treat major eye diseases.

54
$30M · Series B Pureos Bioventures, Karista 11 to 50 Health Tech, Hardware, Biotech, Manufacturing B2B Paris, France •••••••••••@eyevensys.com
Kiro

AI-dirven clinical biology.

50
$14M · Series A Sofinnova Partners 11 to 50 Biotech Paris, France •••••••••••@kiro.bio
PathoQuest

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

50
$8M Eurazeo, Norgine Ventures, Verve Ventures 11 to 50 Health Tech, Biotech B2B Paris, France •••••••••••@pathoquest.com
PiLi

Petroleum-free pigments.

50
$15M · Series A Bpifrance, Elaia 11 to 50 Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing B2B Paris, France •••••••••••@pili.bio
Biomemory

Biomemory designs a low-cost, biobased solution for storing large amounts of computer data on long DNA strands.

50
$5M Bpifrance 1 to 10 Health Tech, Biotech, Data and Analytics, Business Intelligence Paris, France •••••••••••@biomemory-labs.com
Tissium

Niodegradable sealants and adhesives for wound closure.

50
$8M · Series A Bpifrance, CM-CIC Capital Finance, Sofinnova Partners 51 to 100 Health Tech, Hardware, Biotech, Manufacturing B2B Paris, France •••••••••••@tissium.com
BrightHeart

AI to detect congenital heart defects in fetuses.

50
$2M · Seed Sofinnova Partners 1 to 10 AI, Biotech Paris, France •••••••••••@brightheart.fr
Ermium Therapeutics

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

50
$6M · Series A Fountain Healthcare Partners 1 to 10 Health Tech, Biotech, Pharma B2B Paris, France •••••••••••@ermium.com
Stilla Technologies

Stilla Technologies is a Paris-based european biotechnology company.

50
$12M Eurazeo 11 to 50 Health Tech, Biotech, Genetics B2B Paris, France •••••••••••@stillatechnologies.com
LinKinVax

Protein-based vaccines.

50
$7M · Series A In-Q-Tel 1 to 10 Biotech Paris, France •••••••••••@linkinvax.com
Amatera

Non-GMO breeding platform.

50
$1M · Pre Seed PINC, Joyance Partners, Agfunder 1 to 10 Agritech, Biotech B2B Paris, France •••••••••••@amatera.bio
EverImmune

Developer of biotherapeutic products to treat cancer.

50
$3M · Debt Financing Bpifrance 1 to 10 Health Tech, Biotech Paris, France •••••••••••@everimmune.net
nextProtein

nextProtein develops a new large-scale technology that produces a sustainable source of protein.

50
$11M · Series A Blue Oceans Partners 11 to 50 Climate Tech & Green Tech, Agritech, Foodtech, Biotech, Manufacturing B2B Paris, France •••••••••••@nextprotein.co
Qubit Pharmaceuticals

Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.

50
$17M · Seed Quantonation, XAnge 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Paris, France •••••••••••@qubit-pharmaceuticals.com
Corteria Pharmaceuticals

Interceptive therapies for heart failure subpopulations.

50
$12M · Seed OrbiMed, Invivo Capital Partners, Omnes Capital 1 to 10 Health Tech, Biotech Paris, France •••••••••••@corteriapharma.com
FairCraft

Faircraft is leveraging advanced synthetic biology and material science techniques to develop a lab-grown alternative to animal leather.

43
$3M · Seed Kindred Capital, Entrepreneur First 1 to 10 Climate Tech & Green Tech, Fashion, Biotech, Manufacturing B2B Paris, France •••••••••••@faircraft.bio
Core Biogenesis

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

43
$3M · Seed Entrepreneur First, Thia Ventures, XAnge 1 to 10 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Paris, France •••••••••••@corebiogenesis.com
SurgeJUST ADDED HIRING

AI-driven high-dimensional immune system analysis platform.

43
$2M · Pre Seed Kima Ventures, Eurazeo, Boutique Venture Partners 1 to 10 AI, Biotech B2B, SaaS Paris, France •••••••••••@surge.care
Seafood Reboot

PLANT-BASED MARINE SUBSTITUTES WITH ALGAE INGREDIENTS. FOR NATURAL, HEALTHY, SUSTAINABLE FOOD

43
$3M · Pre Seed Founders Future, Demeter Partners 1 to 10 Agritech, Foodtech, Biotech, Manufacturing B2B, B2C Paris, France •••••••••••@seafood-reboot.com
Step Pharma

Manufacturer of oral drugs that specifically inhibit the enzyme cytidine triphosphate synthase 1 (CTPS1).

43
$2M · Seed Bpifrance, Idinvest Partners, AGORANOV 1 to 10 Health Tech, Biotech, Pharma B2B Paris, France •••••••••••@step-ph.com
Honing Biosciences

Bio-therapeutics company that develops and improves cell-based therapies in particular of cancer and other chronic diseases

43
$2M · Pre Seed Elaia 1 to 10 Health Tech, Biotech B2B Paris, France •••••••••••@honing-biosciences.com
ENYO Pharma

Vonafexor drug maker for the treatment of Alport syndrome.

42
$42M · Series C Bpifrance, Sofinnova Partners, OrbiMed 1 to 10 Biotech Lyon, France •••••••••••@enyopharma.com
Antabio

Developer of MEM-ANT3310, a next generation antibacterial combination.

42
$26M · Series B BNP Paribas, EIC Accelerator, Omnes Capital 11 to 50 Health Tech, Biotech Toulouse, France •••••••••••@antabio.com
HawkCellJUST ADDED HIRING

MRI plug-and-play solution developer for veterinary use.

42
$5M · Series A Bpifrance, MIG Capital 11 to 50 Health Tech, Biotech Lyon, France •••••••••••@hawkcell.com
RebrAInJUST ADDED HIRING

Commercial-stage precision neuro-surgery platform.

42
$4M · Seed NACO, Karista 1 to 10 Health Tech, Biotech Bordeaux, France •••••••••••@rebrain.eu
Coave Therapeutics

Gene therapies for rare diseases.

39
$490k · Seed Bpifrance, Idinvest Partners, Omnes Capital 11 to 50 Health Tech, Biotech, Deep Tech B2B Paris, France •••••••••••@coavetx.com
Inato

AI-powered data collecting tool for clinical trials.

39
$1M · Seed Kima Ventures, Cathay Innovation, Serena 11 to 50 Health Tech, AI, Biotech, Machine Learning, Pharma B2B, SaaS Paris, France •••••••••••@inato.com
InSpek

InSpek develops a biological and chemical monitoring systems using integrated photonics.

39
$573k · Pre Seed Quantonation 1 to 10 Biotech, Data and Analytics, Robotics, Navigation and Mapping, Manufacturing, Business Intelligence B2B Paris, France •••••••••••@inspek-solutions.com
WhiteLab Genomics

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

39
$500k · Pre Seed Y Combinator 11 to 50 Health Tech, Biotech, Genetics, Business Intelligence B2B, SaaS Paris, France •••••••••••@whitelabgx.com
Red Horticulture

RED Horticulture specializes in horticulture LED lighting systems, photobiology research, and indoor and greenhouse lighting.

37
$18M · Series A European Circular Bioeconomy Fund (ECBF), Unigrains, Demeter Partners 11 to 50 Climate Tech & Green Tech, Agritech, Biotech, Energy & Nuclear, Manufacturing B2B Lyon, France •••••••••••@horticulture.red
Sensorion

Therapeutic treatment for hearing loss disorders.

37
$38M · Series B Sofinnova Partners, Invus 11 to 50 Health Tech, Biotech B2C Montpellier, France •••••••••••@sensorion.com
Netris Pharma

Developer of therapeutic molecules to treat cancer.

37
$8M · Series A EIC Accelerator 1 to 10 Health Tech, Biotech Lyon, France •••••••••••@netrispharma.com
Alira Health

International advisory firm for healthcare sector.

37
$58M · Series C 101 to 250 Health Tech, Biotech Paris, France •••••••••••@alirahealth.com
InnovaFeed

InnovaFeed is a biotech company producing insect-based protein for the feed industry.

37
$250M · Series D 101 to 250 Biotech, Deep Tech Paris, France •••••••••••@innovafeed.com
ImCheck Therapeutics

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

37
$102M Eurazeo, Earlybird Venture Capital, Andera Partners 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B Marseille, France •••••••••••@imchecktherapeutics.com
AbolerIS Pharma

AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance.

37
$29M · Series A Caixa Capital Risc, Sound Bioventures 1 to 10 Health Tech, Biotech, Pharma B2B Nantes, France •••••••••••@aboleris-pharma.com
Diabeloop

Diabeloop is a medical device company for diabetes and closed-loop system.

37
$73M Supernova Invest, Innovacom 11 to 50 Health Tech, Hardware, Biotech, Manufacturing B2B Grenoble, France •••••••••••@diabeloop.fr
Amolyt Pharma

Peptides for the treatment of rare endocrine and related diseases.

37
$138M · Series C Sofinnova Partners, Intermediate Capital Group 11 to 50 Biotech Lyon, France •••••••••••@amolytpharma.com
Neoplants

Houseplants developer to remove harmful air pollutants.

34
N/A Heartcore, Entrepreneur First, True Ventures 11 to 50 Agritech, Biotech B2C Paris, France •••••••••••@neoplants.co
Depixus

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

34
$35M · Series A 11 to 50 Health Tech, Biotech, Manufacturing, Genetics B2B Paris, France •••••••••••@depixus.com
DeepLife

DeepLife uses deep learning on multi-omics data to model cells and efficiently engineer their behavior.

34
N/A Kima Ventures, Entrepreneur First 1 to 10 Health Tech, AI, Biotech, Machine Learning B2B Paris, France •••••••••••@trydeeplife.org
AlgoTherapeutix

Topical treatments for complex pain.

34
$21M · Series B 1 to 10 Health Tech, Biotech Paris, France •••••••••••@algotx.com
EG 427

Developing pinpoint gene therapy.

34
$5M · Series A 11 to 50 Health Tech, Biotech B2C Paris, France •••••••••••@eg427.com
Corlieve Therapeutics

Corlieve Therapeutics is a biotechnology company.

34
N/A Pureos Bioventures 11 to 50 Health Tech, Biotech B2B Paris, France •••••••••••@corlieve.com
EverImmune

EverImmune provides therapeutic tools related to cancer.

31
$5M · Series A 1 to 10 Health Tech, Biotech, Manufacturing B2B Paris, France •••••••••••@everimmune.com
Damae Medical

DAMAE Medical develops an innovative imaging process for quick and non-invasive skin cancer detection.

31
$5M · Series A 11 to 50 Health Tech, Hardware, Biotech, Business Intelligence B2B, SaaS Paris, France •••••••••••@damae-medical.com
Bon Vivant

Animal-free dairy protein.

31
$15M · Series A Kima Ventures, Founders Future, Sofinnova Partners 11 to 50 Biotech B2C Lyon, France •••••••••••@bonvivant-food.com
Qynapse

Qynapse offers peace of mind by combining MRI scans and AI to produce rapid, actionable insights into central nervous system (CNS) disorders

28
$2M · Seed 11 to 50 Health Tech, AI, Biotech, Deep Tech, Machine Learning, Data and Analytics B2B, SaaS Paris, France •••••••••••@qynapse.com
BforCure

BforCure is a biotech engaged in the manufacture of high speed biosensing solutions such as CHRONOS PCR.

28
$2M · Seed 11 to 50 Health Tech, Biotech, Manufacturing B2B Paris, France •••••••••••@bforcure.com
PDC*line pharma

Personalised therapeutic vaccine developer for colorectal cancer.

26
$8M · Series B 1 to 10 Health Tech, Biotech B2C Grenoble, France •••••••••••@pdc-line-pharma.com
Microphyt

Microphyt researches, develops, produces, and markets natural algae-based products that contribute to weight loss and to brain health.

26
$15M Bpifrance, Sofinnova Partners, Supernova Invest 11 to 50 Health Tech, Agritech, Foodtech, Biotech, Fitness, Energy & Nuclear Montpellier, France •••••••••••@microphyt.eu
Cell-Easy

Cell-Easy is a CDMO that specializes in preclinical and clinical drug development.

26
$8M M Capital Partners 11 to 50 Health Tech, Biotech, Manufacturing B2B Toulouse, France •••••••••••@cell-easy.com
Healshape

Healshape is a 3D bioprinting regenerative medecine company.

26
$6M Demeter Partners 1 to 10 Health Tech, Biotech, Manufacturing B2B Lyon, France •••••••••••@healshape.com
Polaris

Polaris is a leader in the Foodtech sector producing high-quality Omega3 oils, rich in EPA and DHA, from fish historically, and microalgae.

26
$5M · Seed Seventure Partners 11 to 50 Health Tech, Foodtech, Biotech, Manufacturing B2B, B2C Quimper, France •••••••••••@polaris.fr